The Alzheimer’s Disease Assessment Panel combines advanced biomarker analysis, provider-ready reporting, and a complete implementation infrastructure designed to support cognitive health evaluation — without adding operational complexity.
Neurology practices are increasingly seeking objective tools that support more informed cognitive health conversations while maintaining efficient clinical workflows.
More patients are arriving with questions surrounding memory and cognitive decline, raising demand for structured evaluation.
Biomarker insights complement traditional cognitive assessments with measurable, objective data.
Provider-ready reporting and a single workflow make it practical to add a new service line at scale.
Biological changes associated with Alzheimer’s pathology may be present before they are clinically apparent.
Access to objective biomarker information adds clinical perspective that complements cognitive assessments, supporting more informed patient discussions surrounding cognitive health, brain aging, and Alzheimer’s disease risk.
The Alzheimer’s Disease Assessment Panel pairs advanced biomarker analysis with provider-ready reporting and an infrastructure built to integrate into existing practice workflows.
Access measurable biological data associated with Alzheimer’s pathology.
Comprehensive reports designed for clinical review and patient discussions.
Advanced biomarker technology, including FDA-cleared testing components.
Built to integrate into existing practice workflows with minimal operational lift.
Most assessment programs require providers to coordinate laboratories, technology systems, fulfillment, reporting, support, and patient logistics independently.
ExtendingME delivers a complete operational framework designed to simplify implementation and reduce administrative burden.
The ExtendingME Provider Portal centralizes ordering, reporting, patient tracking, and assessment management within one platform.
A closer look at how biomarker science and a single provider workflow support cognitive health evaluation in your practice.
See the Alzheimer’s Disease Assessment Panel in action and get your questions answered. Schedule a 30-minute walkthrough with our team at a time that works for you.
The Alzheimer’s Disease Assessment Panel combines biomarker science, provider-ready reporting, and complete operational infrastructure into one solution designed for neurologists and cognitive health providers.